NYSSTLC Newsletter Fall 2017 A newsletter from the New York State Science and Technology Law Center (NYSSTLC), a NYSTAR-funded resource offering research centers, startups, tech transfer offices, entrepreneurs, accelerators, established companies, and funding sources valuable research on technology commercialization issues. At NYSSTLC, law students—under the guidance of experienced adjunct professors, Dean Bell, Dom Danna, and Chris Horacek—provide research on Intellectual Property, markets, regulatory pathways and other legal issues to help determine next steps toward commercialization. Check out the NYSSTLC website to view guidebooks, webcasts, and videos to learn more about technology commercialization. NEWS FROM THE CENTER NEXUS Incubator This past summer, NYS STLC again saw the completion of technology commercialization research including for: the NYSERDA-sponsored NEXUS Accelerator at High Tech Rochester, the SUNY universities at Binghamton, Buffalo and Stony Brook, the SUNY College of Optometry, and for a StartFast Venture Accelerator group. Currently, fall 2017 has kicked off with work on three comprehensive and six targeted research projects. Traverse Biosciences NYS STLC research client Traverse Biosciences has been accepted into the NIH Commercialization Accelerator Program for Phase II SBIR & STTR awardees. Traverse received a 1.3M Phase II Small Business Technology Transfer (STTR) award in partnership with the School of Dental Medicine at Stony Brook University last year. The Program offers 80 companies a year access to industry connections, the opportunity to receive feedback from experts in the life sciences industry, investment community, regulatory affairs and research as well as the opportunity to deepen market and customer relationships. Read more here. EpiWELL In 2016, Dr. Magnolia Ariza-Nieto participated in a Cornell University PreSeed Workshop, a two and a half day event that brings together experts in the New York community to help companies focus on commercializing hard-science technologies. At the workshop, Ariza-Nieto learned how she could bring her diagnostic epigenetic kit and complementary precision medicine service called epiWELL to market. The NYSSTLC, which sponsors and participates in PreSeed Workshops, worked with Ariza-Nieto at the workshop, which evaluated her technology at an early stage by providing research and information on key issues, including potential purchasers, distribution channels, the size of the opportunity, competitors, and a value proposition. This evaluation allowed Ariza-Nieto to pursue her innovation and she later met with Dr. Shubha Ghosh, director of the Technology Commercialization Law Center, who was vital in providing IP and licensing counsel. In the end, epiWELL and Cornell University agreed to share the epiWELL patent 50/50 and Ariza-Nieto was able to preserve her rights to publish and to patent and eventually bring epiWELL to market. For more on Ariza-Nieto’s story, click here. |